Of all the topics we get pitched here at PharmaTimes, health apps come up more often than most.

It’s not unsurprising – almost everyone, including children and the elderly, has access to a smartphone these days, and it’s only natural that the healthcare industry would want to tap into this potentially-huge market.

But if apps are an ocean waiting to be explored, the waters are still murky – trust, quality and a confusing, crowded market remain ever-present issues. So this month we thought we’d take an in-depth look at some of the lingering questions surrounding health apps: How can they be integrated into care? How can the industry ensure their safety? What does a good health app even look like? Read the features on pages 28-31 and our Smart People interview with NetDoctor co-founder Carl Brandt (p40) to find out.

Elsewhere, we look at how Brexit might affect the pharma supply chain (p25), the increasingly important role of medical affairs (p36), and how pharma sales can embrace patient-centricity (p32).